About us
Being located in the heart of the University of Liege (Belgium) and physically integrated within the CHU of Liege, the GIGA is a major pole of research and development for activities in the biotech area.
|
Detecting peripartum cardiomyopathy
A study by Ingrid Struman’s team, carried out in collaboration with German and South-African researchers at GIGA has revealed a biomarker, a microRNA which makes it possible to distinguish this condition from other cardiac diseases that cause heart failure.
See More |
|
Double win for Pr. Michel Georges and his team
The team of Michel Georges receives the European Research Council (ERC), for a basic research project on process of mutation and recombination (exploiting the unique particularities of the cattle populations); and was selected by Welbio for a project aiming at identifying predisposition genes to the Crohn's disease as new therapeutic targets.
See More |
|
Neuro-oestradiol, a two-speed sexual hormone
Oestradiol, which controls sexual behavior and is known to act in the long-term, has also been shown to be able to act rapidly, much like a neuro-transmitter. In a study published in the Journal of Neuroscience, researchers at the GIGA have demonstrated that this rapid action has a direct effect on the motivational phase of the sexual behavior of male quail but not on copulation.
See More |
|
An innovative biomaker reveals the effect of a natural treatment of articular problems.
An exploratory clinical study has demonstrated the effect of Flexofytol®, a plant based food supplement, on the activity of the articulations.
This effect was confirmed due to a diminution of the degradation of the cartilage revealed by an innovative biomarker developped by the walloon biotech "Artialis", located in the GIGA.
See More |
|
A new star-performer for the inflammatory response
Having demonstrated its protective effect against cancer and asthma, researchers have now also shown that ADAMTS-12 seems to be crucial in order to avoid an exaggerated inflammatory response. These advances have been made possible thanks to a collaboration between a Spanish laboratory, a team from GIGA and the GIGA transgenic platform.
See More |
Last publications
Forthcoming seminars
|
21/05/2013 12:30
Peter Campbell - Sanger Institute Impact of next generation sequencing on the molecular understanding of cancer progression
See More
|
|
28/05/2013 12:30
Ramnik Xavier - Harvard Medical School Post-GWAS analysis of common complex diseases: the case of inflammatory bowel disease
See More
|
All seminars
